R Arendt

1.9k total citations
59 papers, 1.5k citations indexed

About

R Arendt is a scholar working on Cellular and Molecular Neuroscience, Cardiology and Cardiovascular Medicine and Surgery. According to data from OpenAlex, R Arendt has authored 59 papers receiving a total of 1.5k indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Cellular and Molecular Neuroscience, 12 papers in Cardiology and Cardiovascular Medicine and 11 papers in Surgery. Recurrent topics in R Arendt's work include Heart Failure Treatment and Management (7 papers), Neuroscience and Neuropharmacology Research (7 papers) and Epilepsy research and treatment (6 papers). R Arendt is often cited by papers focused on Heart Failure Treatment and Management (7 papers), Neuroscience and Neuropharmacology Research (7 papers) and Epilepsy research and treatment (6 papers). R Arendt collaborates with scholars based in Germany, United States and Switzerland. R Arendt's co-authors include David J. Greenblatt, Ute Wilbert-Lampen, Richard I. Shader, A. Herz, Daniel Liebisch, Thomas Zilker, Christian Seliger, G. Paumgartner, Nicholas M. P. King and Edward M. Sellers and has published in prestigious journals such as New England Journal of Medicine, Circulation and Gastroenterology.

In The Last Decade

R Arendt

56 papers receiving 1.4k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
R Arendt Germany 21 380 291 282 278 256 59 1.5k
Piotr K. Janicki United States 24 283 0.7× 341 1.2× 212 0.8× 589 2.1× 264 1.0× 98 1.7k
Naoki Kotani Japan 28 257 0.7× 304 1.0× 201 0.7× 444 1.6× 215 0.8× 92 2.2k
Masahisa Hirakawa Japan 25 203 0.5× 180 0.6× 408 1.4× 386 1.4× 569 2.2× 120 1.9k
P.J. Salt United Kingdom 14 255 0.7× 195 0.7× 138 0.5× 198 0.7× 335 1.3× 24 1.1k
Paul L. M. van Giersbergen Switzerland 23 343 0.9× 332 1.1× 418 1.5× 111 0.4× 478 1.9× 70 1.6k
Michelle I. Wilde New Zealand 26 215 0.6× 183 0.6× 162 0.6× 461 1.7× 300 1.2× 43 2.0k
M. E. Conolly United Kingdom 26 263 0.7× 839 2.9× 331 1.2× 271 1.0× 476 1.9× 55 2.7k
Takeyoshi Sata Japan 25 401 1.1× 453 1.6× 207 0.7× 366 1.3× 485 1.9× 120 1.9k
Georg Engel Germany 14 534 1.4× 251 0.9× 88 0.3× 193 0.7× 522 2.0× 31 1.6k
W. I. Cranston United Kingdom 27 253 0.7× 434 1.5× 249 0.9× 159 0.6× 316 1.2× 78 2.0k

Countries citing papers authored by R Arendt

Since Specialization
Citations

This map shows the geographic impact of R Arendt's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by R Arendt with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites R Arendt more than expected).

Fields of papers citing papers by R Arendt

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by R Arendt. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by R Arendt. The network helps show where R Arendt may publish in the future.

Co-authorship network of co-authors of R Arendt

This figure shows the co-authorship network connecting the top 25 collaborators of R Arendt. A scholar is included among the top collaborators of R Arendt based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with R Arendt. R Arendt is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Heigl, Franz, et al.. (2013). Immunoadsorption in steroid-refractory multiple sclerosis: Clinical experience in 60 patients. Atherosclerosis Supplements. 14(1). 167–173. 37 indexed citations
2.
Heigl, Franz, et al.. (2013). Lipoprotein apheresis standard for apheresis competence centers – An updated synthesis and amendment to pre-existing standards. Atherosclerosis Supplements. 14(1). 57–65. 10 indexed citations
3.
Heigl, Franz, et al.. (2009). Indication and Implementation of Lipidapheresis, Rheopheresis, or Immunoadsorption (Lessons learnt from Germany's largest apheresis center). Atherosclerosis Supplements. 10(5). 137–141. 9 indexed citations
4.
Weis, Michael, Stephen M. Wildhirt, Christian Schulze, et al.. (1999). Endothelin in coronary endothelial dysfunction early after human heart transplantation. The Journal of Heart and Lung Transplantation. 18(11). 1071–1079. 31 indexed citations
5.
Samtleben, W., Karl‐Siegfried Boos, Peter Fraunberger, et al.. (1997). H.E.L.P. in Gram-negative, Refractory Septic Shock: First Clinical Experiences.(Workshop1-12). 16(1). 91–96. 2 indexed citations
6.
Schmoeckel, Michael, Georg Nollert, Vincent Young, et al.. (1996). PREVENTION OF HYPERACUTE REJECTION BY HUMAN DECAY ACCELERATING FACTOR IN XENOGENEIC PERFUSED WORKING HEARTS. Transplantation. 62(6). 729–734. 62 indexed citations
7.
Arendt, R, et al.. (1993). Increased endothelin plasma concentrations in patients with coronary artery disease or hyperlipoproteinemia without coronary events. Research in Experimental Medicine. 193(1). 225–230. 35 indexed citations
8.
Ehrenreich, Hannelore, Fred Sinowatz, Rüdiger Schulz, R Arendt, & F. D. Goebel. (1989). Immunoreactive atrial natriuretic peptide (ANP) in endoscopic biopsies of the human gastrointestinal tract. Research in Experimental Medicine. 189(6). 421–425. 14 indexed citations
9.
Gerbes, Alexander L., et al.. (1989). Atrial natriuretic factor and renin-aldosterone in volume regulation of patients with cirrhosis†. Hepatology. 9(3). 417–422. 60 indexed citations
10.
Vollmar, Angelika M., et al.. (1988). Atrial Natriuretic Peptide in Bovine Corpus Luteum*. Endocrinology. 123(2). 762–767. 37 indexed citations
11.
Gerbes, Alexander L., Angelika M. Vollmar, Yining Xie, & R Arendt. (1988). Presence of the atrial natriuretic factor (ANF) in human ascitic fluid. Life Sciences. 43(19). 1517–1521. 2 indexed citations
12.
Vollmar, Angelika M., R Arendt, & Rüdiger Schulz. (1987). The effect of opioids on rat plasma atrial natriuretic peptide. European Journal of Pharmacology. 143(3). 315–321. 16 indexed citations
13.
Arendt, Thomas, M Barten, Volker Lakner, & R Arendt. (1987). Diffuse Gastric Antral Vascular Ectasia: Cause of Chronic Gastrointestinal Blood Loss. Endoscopy. 19(5). 218–220. 32 indexed citations
14.
Arendt, R, et al.. (1987). Atrial natriuretic factor. Journal of Hepatology. 5(1). 123–132. 47 indexed citations
15.
Arendt, R & Alexander L. Gerbes. (1986). Atrialer natriuretischer Faktor. DMW - Deutsche Medizinische Wochenschrift. 2 indexed citations
16.
King, Nicholas M. P., R Arendt, & David J. Greenblatt. (1985). Pharmacologic properties of acebutolol: Relationship of hydrophilicity to central nervous system penetration. American Heart Journal. 109(5). 1120–1125. 10 indexed citations
17.
Arendt, R, David J. Greenblatt, John D. Bonin, et al.. (1983). In vitro correlates of benzodiazepine cerebrospinal fluid uptake, pharmacodynamic action and peripheral distribution.. Journal of Pharmacology and Experimental Therapeutics. 227(1). 98–106. 124 indexed citations
18.
Jonas, Ludwig, et al.. (1982). [Pancreatic findings after ductal occlusion in rats. A histological and biochemical study].. PubMed. 42(4). 138–47. 1 indexed citations
19.
Abernethy, D. R., David J. Greenblatt, Marcia Divoll, & R Arendt. (1982). Impairment of diazepam clearance with low-dose oral contraceptive steroid therapy. Clinical Pharmacology & Therapeutics. 31(2). 198–199. 6 indexed citations
20.
Arendt, R, et al.. (1977). The effect of metoclopramide on gastro-oesophageal reflux.. Munich Personal RePEc Archive (Ludwig Maximilian University of Munich). 20(3). 155–62. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Piotr K. Janicki Breakdown of academic impact, for papers by Naoki Kotani Breakdown of academic impact, for papers by Masahisa Hirakawa Breakdown of academic impact, for papers by P.J. Salt Breakdown of academic impact, for papers by Paul L. M. van Giersbergen Breakdown of academic impact, for papers by Michelle I. Wilde Breakdown of academic impact, for papers by M. E. Conolly Breakdown of academic impact, for papers by Takeyoshi Sata Breakdown of academic impact, for papers by Georg Engel Breakdown of academic impact, for papers by W. I. Cranston
Rankless by CCL
2026